Navigation Links
Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
Date:11/3/2008

LAS VEGAS, Nov. 3 /PRNewswire/ -- Altogen Biosystems (http://www.altogen.com) announced launch of novel Nanoparticle-based transfection reagent for use in laboratories and research facilities for animal testing. Transfection is one of the major laboratory methods used to introduce DNA and RNA molecules into cells and tissues. This technique makes it possible to cross the cellular barriers and deliver a gene or a small interfering RNA (siRNA) into the cells for research or therapeutic purposes.

The company has previously developed lipid- and polymer-based in vivo transfection reagents (http://www.altogen.com/mirna.htm) used for testing pharmaceuticals in animals. Altogen Biosystems recently developed novel nanoparticles biotechnology that allows highly efficient delivery of various biomolecules into animal tissues via systemic administration, as well as intraperitoneal and direct intratumoral injections.

Altogen Biosystems is focusing on commercializing pharma- and bio-technologies, as well as providing custom laboratory research services. The company now offers such innovative services as generation of stably-transformed cell lines in 28-days, as well as gene silencing and RNAi services (http://www.altogen.com/support.htm).

About Altogen Biosystems

Altogen Biosystems is a life sciences company located in Las Vegas, Nevada. The company is dedicated to the engineering, marketing and manufacture of transfection reagents and kits for intracellular and tissue-targeted delivery of biomolecules (http://www.altogen.com).

Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, including generation of stable cell lines, gene silencing and RNA Interference (RNAi) services,
'/>"/>

SOURCE Altogen Biosystems
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
2. Enigma Diagnostics Announces Patent Licence With Applied Biosystems
3. Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
4. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
5. Open Biosystems Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
6. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
7. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
8. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
9. Primera Biosystems Raises $21 Million in Series B Private Round
10. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...he Human Anthrax Vaccine Program must be stopped. ...e film "A Call to Arms:2009 Edition" and...mmunity: The Human Anthrax Vaccine Story" to ...er of top secret government science turned into fo...lity to its victims. It is available for world-wi...
(Date:11/4/2009)... 4 Star Scientific, In...pany plans to introduce the CigRx(TM) nutraceutica...Pharmaceuticals, for worldwide marketing and sales...sdaq: VTIV). inVentiv Health offers a complete ra... of the product lifecycle, in a range of healthcar...
(Date:11/4/2009)...ov. 4 Onyx Pharmaceutica...will present at the Credit Suisse 18th Annual Heal...30 a.m. Mountain Time (8:30 a.m. Pacific Time). I... presentation on our website at: http://www.onyx...s recommended that listeners log on 15 minutes ear...
(Date:11/4/2009)... Pa., Nov. 4 Emerson Resources, ..., today announced that it has formed a strategic p...rch organization that specializes in the agrichemi...business development capabilities. The exclusive p...eran Robert Westbrook, CEO of Bio Research, who is...
Breaking Biology Technology:Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Emerson Resources Forges Strategic Partnership with Bio Research 2
... began to develop Bone Care International,s trade ...y that purchased Bone Care in 2005 is suing three ...hroma, Inc . , , Genzyme Corp . filed the suit in ...rict of Wisconsin , claiming that the plaintiffs a...are based on BCI,s "confidential and proprietary i...
...l for fishing enthusiasts may not guarantee you ca... some promising spots to cast a lure. , ,A newly d...m integrates topographical maps of about 1,000 Wi...to provide anglers a resource for targeting ideal ...n Internet browser and Flash Viewer. , ,Lake-Link ...
...eviewed the top 100 most wired hospitals in the U....e top 100. While this is a sign of progress in U.S...n of U.S. hospitals is U.S. News & World Report ...tals ). , ,The 2006 survey had some very interesti...he Midwest from this national survey. In this surv...
Other Biology Technology:Genzyme sues former Bone Care employees 2Genzyme sues former Bone Care employees 3Online fishing site introduces interactive maps 2Online fishing site introduces interactive maps 3Midwest shines among best hospitals in U.S. 2Midwest shines among best hospitals in U.S. 3Midwest shines among best hospitals in U.S. 4Midwest shines among best hospitals in U.S. 5Midwest shines among best hospitals in U.S. 6Midwest shines among best hospitals in U.S. 7Midwest shines among best hospitals in U.S. 8
(Date:11/8/2009)...HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLEC...VES , An Indiana University study involving adu...adults increased their personal health knowledge a..., Adults with ID, an internationally accepted ter...es of obesity, physical inactivity and preventable...
(Date:11/6/2009)...ADELPHIA (November 06, 2009) The Monell Center an...ts of the Beijing International Meeting on Taste a...ation with the CAS, the meeting will be the first ...d in China. , Alan Leshner, Chief Executive Offi...cience and Executive Publisher of Science magazine...
(Date:11/4/2009)...EADS: (top news in natural science) , United S...s uses less water today than it did 35 years ago, ... in water use are partly attributable to alternati...ent irrigation systems. According to the latest US... in the United States goes to cooling thermoelectr...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 1FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 3FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 4FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 5FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 6Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 47443 1Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 47443 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 1PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 3
...ght viral infections, immune cells called macropha...d of the disease in the body. Now researchers at W...is have uncovered how macrophages keep from succum...chanism may be a way to speed recovery from respir...pecific protein produced in the course of respirat...
... to forest greenery, the mold Aspergillus fumigat...s impact. The most common mold causing infection, ... attacks--and even deadly infections among people ...ber 22 issue of the journal Nature , scientists a...eir collaborators report the mold,s sequenced geno...
...arved houseplant and flood-covered crops have some...ach and researchers on two continents, potentially... human health. , The research, which appeared onli... the journal Nature, involved a tandem of basic-sc...cations, the scientists say. , First, Swedish pla...
Other Biology News:Shorter colds, milder flu may follow from newly revealed immune mechanism 2Shorter colds, milder flu may follow from newly revealed immune mechanism 3Breaking the mold: Research teams sequence three fungus genomes 2Membrane research opens window to benefits for plants, humans 2Membrane research opens window to benefits for plants, humans 3
...cally collected via cardiac puncture from 3 to 4 w... is then centrifuged and frozen at -70C. The compl...led at 4C then stored at -70C. DIRECT SALES FROM P...FREEZ COMPLEMENT, YOU CAN NOW BUY DIRECTLY FROM TH...
Thermal Grayscale USB Printer for Imaging Systems; USB Connection from Alpha Innotech
GIBCO Newborn Calf Serum Heat-Inactivated from Invitrogen
Ready-To-Use IHC Bluing Reagent from Bethyl Laboratories
Biology Products: